Changes

681 bytes added ,  15:35, 11 October 2018
Line 23: Line 23:  
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
 
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
   −
According to "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues", blah, blah.
+
According to "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues",
 +
"...clinical and morphologic presentations associated with FGFR1 rearrangement are variable, and include not only presentation as a myeloproliferative neoplasm with eosinophilia, but also as AML and they may even present as, or evolve to, precursor T or B lymphoblastic leukaemia/lymphoma with prominent eosinphils." (p.28).
 +
 
 +
FGFR1 rearrangements are used to rule out diagnoses of Chronic Eosinophilic Leukaemia (p.54) and Myeloproliferative neoplasm,unclassifiable (p.66).
 +
 
 +
In the case of FGFR1-related disease,
 +
a lymphomatous presentation is common,
 +
particularly T-LBL with accompanying eosinophilia. Other patients have had CEL,
 +
precursor-B lymphoblastic leukaemia/
 +
lymphoma or AML. (.70).
    
==Gene Overview==
 
==Gene Overview==
436

edits